Lataa...

Circulating Tumors Cells as Biomarkers: Progress Toward Biomarker Qualification

Personalized cancer medicine requires the development of tumor-specific biomarkers to optimize selection of targeted therapies and to better assess response to therapy. Current efforts in several tumor types have shown that patients in whom circulating tumor cells (CTCs) are detected have an inferio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Danila, Daniel C., Pantel, Klaus, Fleisher, Martin, Scher, Howard I.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3985131/
https://ncbi.nlm.nih.gov/pubmed/22157288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e31823e69ac
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!